vasopressin

Generic: vasopressin

Labeler: fresenius kabi usa, llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name vasopressin
Generic Name vasopressin
Labeler fresenius kabi usa, llc
Dosage Form INJECTION, SOLUTION
Routes
INTRAVENOUS
Active Ingredients

vasopressin 20 [USP'U]/mL

Manufacturer
Fresenius Kabi USA, LLC

Identifiers & Regulatory

Product NDC 65219-039
Product ID 65219-039_9fa80e75-4058-47f2-be6f-36d33062abd6
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA213206
Listing Expiration 2026-12-31
Marketing Start 2023-05-26

Pharmacologic Class

Chemical Structure
vasopressins [cs]
Physiologic Effect
vasoconstriction [pe] decreased diuresis [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 65219039
Hyphenated Format 65219-039

Supplemental Identifiers

RxCUI
2103182
UPC
0365219039006
UNII
Y4907O6MFD
NUI
M0022562 N0000009908 N0000175360

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name vasopressin (source: ndc)
Generic Name vasopressin (source: ndc)
Application Number ANDA213206 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 20 [USP'U]/mL
source: ndc
Packaging
  • 25 VIAL, SINGLE-DOSE in 1 TRAY (65219-039-01) / 1 mL in 1 VIAL, SINGLE-DOSE (65219-039-00)
source: ndc

Packages (1)

Ingredients (1)

vasopressin (20 [USP'U]/mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "9fa80e75-4058-47f2-be6f-36d33062abd6", "openfda": {"nui": ["M0022562", "N0000009908", "N0000175360"], "upc": ["0365219039006"], "unii": ["Y4907O6MFD"], "rxcui": ["2103182"], "spl_set_id": ["50aef1e8-0a70-466d-93cd-c1b9ed489839"], "pharm_class_cs": ["Vasopressins [CS]"], "pharm_class_pe": ["Vasoconstriction [PE]", "Decreased Diuresis [PE]"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "25 VIAL, SINGLE-DOSE in 1 TRAY (65219-039-01)  / 1 mL in 1 VIAL, SINGLE-DOSE (65219-039-00)", "package_ndc": "65219-039-01", "marketing_start_date": "20230526"}], "brand_name": "VASOPRESSIN", "product_id": "65219-039_9fa80e75-4058-47f2-be6f-36d33062abd6", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Decreased Diuresis [PE]", "Vasoconstriction [PE]", "Vasopressins [CS]"], "product_ndc": "65219-039", "generic_name": "VASOPRESSIN", "labeler_name": "Fresenius Kabi USA, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "VASOPRESSIN", "active_ingredients": [{"name": "VASOPRESSIN", "strength": "20 [USP'U]/mL"}], "application_number": "ANDA213206", "marketing_category": "ANDA", "marketing_start_date": "20230526", "listing_expiration_date": "20261231"}